Current track



PharmEasy Seeing ‘Exceptional Growth’, Waits For IPO | Startup Central | ET Now

Written by on January 21, 2023

A Healthcare Company & subsidiary of API Holdings, PharmEasy, was all set for an IPO. Until it rolled back its plans, withdrawing its Draft Red Herring Prospectus (DRHP). Why did the company decide on it? What are the future plans? What does the growth trajectory look like? What is the story behind the Goldman Sachs loan rumor with the company? The Co-founder and Chief Executive Officer of API Holdings, Siddharth Shah, talks about all that and more, as he also addresses & clarifies all the rumors around PharmEasy’s Finances. Tune into this edition of Startup Central with Nayantara Rai to know more.

#pharmeasy #healthcare #startupcentral
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ►

Subscribe Now To Our Network Channels :-
Times Now :
The NewsHour Debate :

To Stay Updated Download the Times Now App :-
Android Google Play :
Apple App Store :

Social Media Links :-
Twitter –
Facebook –
G+ –
Website –

To know more about latest IPO gmp please visit